EP3139932
Meðferðaráform fyrir tíakúmisínefnasamband
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.5.2015EP published:
1.8.2018EP application number:
15731245.5
EP translation filed:
31.10.2018Grant published:
15.11.2018EPO information:
European Patent Register
Max expiry date:
10.5.2035Expiry date:
10.5.2026Next due date:
31.5.2026
Title:
TREATMENT REGIMEN FOR TIACUMICIN COMPOUND
Timeline
Today
11.5.2015EP application
1.8.2018EP Publication
31.10.2018Translation submitted
15.11.2018Registration published
10.5.2026Expires
Owner
Name:
Tillots Pharma AGAddress:
Baslerstrasse 15, CH-4310, Rheinfelden, CH
Inventor
Name:
KARAS, Andreas JohannisAddress:
NL-2333 BE Leiden, NL
Name:
LONGSHAW, Christopher MarkAddress:
NL-2333 BE Leiden, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
14075031Date:
9.5.2014Country:
EP
Classification
Categories:
A61K 31/7048, A61P 31/04
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 23.4.2019
Expires: 10.5.2020
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 20.4.2020
Expires: 10.5.2021
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 18.5.2021
Expires: 10.5.2022
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 5.4.2022
Expires: 10.5.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 12.4.2023
Expires: 10.5.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.4.2024
Expires: 10.5.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 29.4.2025
Expires: 10.5.2026
Payer: Árnason Faktor ehf.